Lv5
870 积分 2023-01-29 加入
Safety of PARP inhibitors as maintenance therapy in ovarian cancer
15小时前
已完结
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
1个月前
已完结
侵袭性霉菌感染实验室诊断临床应用专家共识
1个月前
已完结
[A randomized double-blinded placebo-controlled clinical trial of minodronate tablet in postmenopausal Chinese women with osteoporosis]
4个月前
已完结
Psoriasis Prevalence in Adults in the United States
5个月前
已完结
Acute myeloid leukemia, version 3.2019
7个月前
已关闭
OptoBase: A Web Platform for Molecular Optogenetics
8个月前
已完结
Secular trend in disease burden of leukemia and its subtypes in China from 1990 to 2019 and its projection in 25 years
9个月前
已关闭
Sexually Transmitted Infections Treatment Guidelines, 2021
9个月前
已完结
皖公网安备34019202002308
